MA33514B1 - Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe) - Google Patents

Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe)

Info

Publication number
MA33514B1
MA33514B1 MA34612A MA34612A MA33514B1 MA 33514 B1 MA33514 B1 MA 33514B1 MA 34612 A MA34612 A MA 34612A MA 34612 A MA34612 A MA 34612A MA 33514 B1 MA33514 B1 MA 33514B1
Authority
MA
Morocco
Prior art keywords
leishmaniasis
diagnosis
protein extracts
parasitic disease
ribosome protein
Prior art date
Application number
MA34612A
Other languages
Arabic (ar)
English (en)
Inventor
Manuel Soto-Álvarez
García Laura Ramírez
Eduardo Antonio Ferraz Coelho
Carlos Alonso-Bedate
Original Assignee
Leti Sl Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leti Sl Lab filed Critical Leti Sl Lab
Publication of MA33514B1 publication Critical patent/MA33514B1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Secondary Cells (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'INVENTION PORTE SUR UN PROCÉDÉ DE DIAGNOSTIC DE LEISHMANIOSE À L'AIDE D'UN RPE.
MA34612A 2009-07-13 2012-02-08 Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe) MA33514B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09165282 2009-07-13
US26721409P 2009-12-07 2009-12-07
PCT/EP2010/060058 WO2011006891A1 (fr) 2009-07-13 2010-07-13 Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe)

Publications (1)

Publication Number Publication Date
MA33514B1 true MA33514B1 (fr) 2012-08-01

Family

ID=41211952

Family Applications (1)

Application Number Title Priority Date Filing Date
MA34612A MA33514B1 (fr) 2009-07-13 2012-02-08 Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe)

Country Status (20)

Country Link
US (1) US8969019B2 (fr)
EP (1) EP2454593A1 (fr)
JP (1) JP5805635B2 (fr)
KR (1) KR20120061082A (fr)
CN (1) CN102483413A (fr)
AP (1) AP3516A (fr)
AU (1) AU2010272566B2 (fr)
BR (1) BR112012000679A2 (fr)
CA (1) CA2767865A1 (fr)
CO (1) CO6480993A2 (fr)
EC (1) ECSP12011662A (fr)
IL (1) IL217528A (fr)
IN (1) IN2012DN00401A (fr)
MA (1) MA33514B1 (fr)
MX (1) MX2012000675A (fr)
PE (1) PE20120818A1 (fr)
RU (1) RU2558233C2 (fr)
TN (1) TN2012000014A1 (fr)
WO (1) WO2011006891A1 (fr)
ZA (1) ZA201200295B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA110310855B1 (ar) * 2009-11-13 2014-09-16 Laboratories Leti S L Unipersonal استخدام مصدر l3 و/ أو l5 كلقاح أو كوسيلة تشخيصية لمرض طفيلي
JP2016053535A (ja) * 2014-09-04 2016-04-14 国立大学法人 東京大学 皮膚型リーシュマニア症の検査用試薬又はキット、及び皮膚型リーシュマニア症の検査方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5359681A (en) 1993-01-11 1994-10-25 University Of Washington Fiber optic sensor and methods and apparatus relating thereto
US5912166A (en) 1995-04-21 1999-06-15 Corixa Corporation Compounds and methods for diagnosis of leishmaniasis
US6613337B1 (en) 1997-02-12 2003-09-02 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
US6500437B1 (en) * 1995-09-22 2002-12-31 Corixa Corporation Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
PT1141305E (pt) * 1998-12-23 2006-10-31 Leti Lab Gene quimerico formado pelas sequencias de adn que codifica os determinantes antigenicos de quatro proteinas de l. infantum
SI1141305T1 (sl) * 1998-12-23 2006-10-31 Leti Lab Himerni gen, ki kodira antigenske determinante stirih proteinov L. Infantum
ES2169995B1 (es) 2000-04-17 2003-12-01 Leti Lab Composicion a base de la proteina lip2a y su uso en la preparacion de un medicamento para suscitar una respuesta inmune contra un antigeno.
CA2498604A1 (fr) * 2002-09-20 2004-04-01 Akzo Nobel N.V. Vaccin de parasite vivant attenue
WO2005044301A2 (fr) 2003-11-05 2005-05-19 C.B.F. Leti, S.L. Unipersonal Application d'histones specifiques au traitement de maladies parasitaires

Also Published As

Publication number Publication date
TN2012000014A1 (en) 2013-09-19
AP3516A (en) 2016-01-11
KR20120061082A (ko) 2012-06-12
JP5805635B2 (ja) 2015-11-04
CO6480993A2 (es) 2012-07-16
PE20120818A1 (es) 2012-07-12
RU2558233C2 (ru) 2015-07-27
EP2454593A1 (fr) 2012-05-23
IN2012DN00401A (fr) 2015-08-21
AP2012006118A0 (en) 2012-02-29
MX2012000675A (es) 2012-06-08
US8969019B2 (en) 2015-03-03
BR112012000679A2 (pt) 2016-11-01
US20120178109A1 (en) 2012-07-12
JP2012533074A (ja) 2012-12-20
AU2010272566B2 (en) 2015-03-26
CN102483413A (zh) 2012-05-30
RU2012104855A (ru) 2013-08-20
ECSP12011662A (es) 2012-06-29
AU2010272566A1 (en) 2012-02-02
WO2011006891A1 (fr) 2011-01-20
CA2767865A1 (fr) 2011-01-20
IL217528A (en) 2016-05-31
IL217528A0 (en) 2012-02-29
ZA201200295B (en) 2012-09-26

Similar Documents

Publication Publication Date Title
EP2331955A4 (fr) Méthode de diagnostic d' une maladie respiratoire
EP2432385A4 (fr) Système thermoacoustique destiné à l'analyse de tissu
EP2677038A4 (fr) Kit de diagnostic simultané d'une maladie due à un virus respiratoire
EP2158326A4 (fr) Marqueurs biologiques pour le diagnostic d'une maladie auto-immune
AR066987A1 (es) Anticuerpo monoclonal contra proteina beta-amiloide
UA107574C2 (ru) Гуманизированное антитело, специфическое к протофибрилярной формы бета-амилоидного пептида
EP2338326A4 (fr) Système d'éclairage pour la prévention d'un dommage causé par une maladie végétale
EP2425356A4 (fr) Système mis en uvre par un ordinateur et procédé pour estimer une condition neuropsychiatrique d'un sujet humain
UY32535A (es) Métodos e intermediarios para la preparación de agentes farmacéuticos
FR2890566B1 (fr) Systeme de desinfection d'instruments medicaux
EP2795325A4 (fr) Méthodes de diagnostic de la maladie d'alzheimer
EP2216651A4 (fr) Biomarqueur pour le diagnostic d'une maladie hépatique
EP2198292A4 (fr) Meilleur diagnostic de la maladie d'alzheimer
EP2046199A4 (fr) Procédé d'acquisition d'une réponse physiologique
EP3785014A4 (fr) Méthodes de diagnostic d'une maladie par cytométrie en microflux
EP4264231A4 (fr) Système d'imagerie cinématique
FR2920663B1 (fr) Instrument d'aide a la pose d'un systeme d'osteosynthese.
EP2014316A4 (fr) Procede de preparation d'un organe en vue d'une transplantation
FR2899480B1 (fr) Systeme de desinfection d'instruments medicaux
GT200600286A (es) Diagnostico de artritis reumatoide por imagenes opticas
EP2711710A4 (fr) Diagnostic de maladies infectieuses des voies respiratoires à l'aide d'échantillons d'urine
MA33514B1 (fr) Diagnostic d'une maladie parasitaire telle que la leishmaniose à l'aide d'un extrait de protéine ribosomique (rpe)
BRPI1013003A2 (pt) "disposições de acoplamento e métodos para fixação de ferramentas a instrumentos cirúrgicos ultra-sônicos"
EP3798309A4 (fr) Procédé de diagnostic d'une infection par helicobacter suis
EP2791676A4 (fr) Méthodes de diagnostic de la maladie d'alzheimer